A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Clinical trial NCT05979051 · RECRUITING
Trial details
- NCT number
- NCT05979051
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2028-12-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.